Product
MenABCWY-2Gen
1 clinical trial
2 indications
Indication
InfectionsIndication
MeningococcalClinical trial
A Phase II, Randomized, Partially Blinded Study to Assess the Safety, Tolerability and Immunogenicity of Meningococcal Combined ABCWY Vaccine When Administered to Healthy InfantsStatus: Active (not recruiting), Estimated PCD: 2025-03-13